Chimerix Statistics
Total Valuation
Chimerix has a market cap or net worth of $79.66 million. The enterprise value is -$98.36 million.
| Market Cap | 79.66M |
| Enterprise Value | -98.36M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Chimerix has 89.21 million shares outstanding. The number of shares has decreased by -0.19% in one year.
| Shares Outstanding | 89.21M |
| Shares Change (YoY) | -0.19% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 1.34% |
| Owned by Institutions (%) | 50.01% |
| Float | 74.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 1.21 |
| PS Ratio | 256.70 |
| Forward PS | 407.70 |
| PB Ratio | 0.43 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.25, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.25 |
| Quick Ratio | 9.91 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -37.90% and return on invested capital (ROIC) is -47.89%.
| Return on Equity (ROE) | -37.90% |
| Return on Assets (ROA) | -35.00% |
| Return on Capital (ROIC) | -47.89% |
| Revenue Per Employee | $4,500 |
| Profits Per Employee | -$1.14M |
| Employee Count | 72 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.20% in the last 52 weeks. The beta is 1.10, so Chimerix's price volatility has been higher than the market average.
| Beta (1Y) | 1.10 |
| 52-Week Price Change | -24.20% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 1.03 |
| Relative Strength Index (RSI) | 38.02 |
| Average Volume (30 Days) | 426,762 |
Short Selling Information
The latest short interest is 1.24 million, so 1.39% of the outstanding shares have been sold short.
| Short Interest | 1.24M |
| Short Previous Month | 1.26M |
| Short % of Shares Out | 1.39% |
| Short % of Float | 1.67% |
| Short Ratio (days to cover) | 2.51 |
Income Statement
In the last 12 months, Chimerix had revenue of $324,000 and -$82.10 million in losses. Loss per share was -$0.93.
| Revenue | 324,000 |
| Gross Profit | 324,000 |
| Operating Income | -93.07M |
| Pretax Income | -82.10M |
| Net Income | -82.10M |
| EBITDA | -82.09M |
| EBIT | -82.10M |
| Loss Per Share | -$0.93 |
Balance Sheet
The company has $182.84 million in cash and $1.30 million in debt, giving a net cash position of $181.53 million or $2.03 per share.
| Cash & Cash Equivalents | 182.84M |
| Total Debt | 1.30M |
| Net Cash | 181.53M |
| Net Cash Per Share | $2.03 |
| Equity / Book Value | 193.03M |
| Book Value Per Share | 2.16 |
| Working Capital | 170.67M |
Cash Flow
In the last 12 months, operating cash flow was -$69.09 million and capital expenditures -$81,000, giving a free cash flow of -$69.17 million.
| Operating Cash Flow | -69.09M |
| Capital Expenditures | -81,000 |
| Free Cash Flow | -69.17M |
| FCF Per Share | -$0.78 |
Margins
Gross margin is 100.00%, with operating and profit margins of -28,723.77% and -25,337.96%.
| Gross Margin | 100.00% |
| Operating Margin | -28,723.77% |
| Pretax Margin | -25,337.96% |
| Profit Margin | -25,337.96% |
| EBITDA Margin | -25,337.65% |
| EBIT Margin | -25,337.96% |
| FCF Margin | -21,348.46% |
Dividends & Yields
Chimerix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.19% |
| Shareholder Yield | 0.19% |
| Earnings Yield | -98.71% |
| FCF Yield | -83.16% |
Analyst Forecast
The average price target for Chimerix is $8.00, which is 795.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 795.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 259.86% |
| EPS Growth Forecast (5Y) | -35.31% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Chimerix has an Altman Z-Score of -3.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.02 |
| Piotroski F-Score | 3 |